Andrew Combs, Chief Chemistry Officer: Prelude Therapeutics PRLD Buy · Filed 24/12/26

Trade details

Type: Insider buy
Amount: $82,200
Shares · price: 60,000 sh · $1.37 a share
Held after: 377,623 sh
Stock: Prelude Therapeutics PRLD
Person: Andrew CombsChief Chemistry Officer
Trade date: 24/12/23
Filed: 24/12/26
Days to filing: 3 days

First buy since 2023

Insiders buying this week: 3 insiders
Holding change: +18.9%

Prelude Therapeutics trades, last 26 weeks

What else happened in Prelude Therapeutics around then

Filed or reported within 30 days of the trade day · 24/11/23~25/01/22

Andrew Combs's recent trades

Andrew CombsChief Chemistry Officer
BuyPrelude Therapeutics
Buy
Prelude Therapeutics
PRLD
$69K
100,000 sh
$69K
Filed 25/03/27
Traded 25/03/25
Andrew CombsChief Chemistry Officer
BuyPrelude Therapeutics
Buy
Prelude Therapeutics
PRLD
$3,536
3,075 sh
$3,536
Filed 24/12/26
Traded 24/12/20